Keywords: موتاسیون درمان هدفمند; Adjuvant chemotherapy; Colorectal neoplasms; Molecular targeted therapy; Practice guidelines as topic; Quality of health care;
مقالات ISI موتاسیون درمان هدفمند (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: موتاسیون درمان هدفمند; Alveolar soft part sarcoma; Molecular targeted therapy; Tyrosine kinase inhibitor; Drug resistance;
Keywords: موتاسیون درمان هدفمند; Review literature as topic; Molecular targeted therapy; Colorectal neoplasm; Neoplasm metastasis; Aged;
Keywords: موتاسیون درمان هدفمند; DNA copy number variation; Metastatic disease; Molecular targeted therapy; Prognostic factors; RCC;
Keywords: موتاسیون درمان هدفمند; periodontal disease; host-pathogen interactions; molecular targeted therapy; nanomedicine; nanotoxicity;
Keywords: موتاسیون درمان هدفمند; Biological markers; Molecular targeted therapy; Breast cancer;
Keywords: موتاسیون درمان هدفمند; Molecular targeted therapy; Cancer; Small molecule; Monoclonal antibody; Therapeutic cancer vaccine; Gene therapy;
Keywords: موتاسیون درمان هدفمند; Molecular tumour board; Personalised medicine; Personalised oncology; Precision medicine; Precision oncology; Molecular targeted therapy; Next-generation sequencing; Deep sequencing;
Keywords: موتاسیون درمان هدفمند; Antineoplastic agents; Costs and cost analysis; Drug-related side effects and adverse reactions; Treatment outcome; Immunotherapy; Molecular targeted therapy;
Keywords: موتاسیون درمان هدفمند; Glioblastoma; Cancer stem cell; Nanotechnology; Brain drug delivery; Molecular targeted therapy; Lipid nanoparticle;
Keywords: موتاسیون درمان هدفمند; kidney; carcinoma; renal cell; neoplasm metastasis; interleukin-2; molecular targeted therapy; CR; complete response; ECOG; Eastern Cooperative Oncology Group; HDIL-2; high dose IL-2; IL-2; interleukin-2; mRCC; metastatic RCC; OS; overall survival; PD; pr
Keywords: موتاسیون درمان هدفمند; Liver cancer; Sorafenib; Molecular targeted therapy; Drug resistance;
Keywords: موتاسیون درمان هدفمند; Giant cell tumours; Surgical procedures; Operative; Radiography; Immunotherapy; Molecular targeted therapy;
Keywords: موتاسیون درمان هدفمند; Radiotherapy; Head and neck cancer; Head and neck squamous cell carcinoma; Radiation-sensitizing agents; Molecular targeted therapy; Radiation resistance; Radioresistance; DNA damage;
Keywords: موتاسیون درمان هدفمند; Molecular imaging; Molecular targeted therapy; Chemotherapy; Drug response; Metabolic activityHDRA, histoculture drug response assay; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; EGFR, epidermal growth factor receptor; PET, positron
Keywords: موتاسیون درمان هدفمند; Acute respiratory failure; Intensive care unit; Molecular targeted therapy; Non-small-cell lung cancer; Tyrosine kinase inhibitors;
Keywords: موتاسیون درمان هدفمند; Fatigue; gastrointestinal stromal tumors; molecular targeted therapy; quality of life;
Keywords: موتاسیون درمان هدفمند; Prostate cancer; Molecular targeted therapy; Next-generation sequencing; Genetic aberrations;
Keywords: موتاسیون درمان هدفمند; Antibodies, Monoclonal; Colitis, Ulcerative; Crohn Disease; Inflammatory Bowel Diseases; Molecular Targeted Therapy; Drug MonitoringColite Ulcerosa; Doença de Crohn; Doença Inflamatória Intestinal; Terapia Molecular Dirigida; Monitorização de Medicamentos
Keywords: موتاسیون درمان هدفمند; Head and neck squamous cell carcinoma; Radiotherapy; Molecular targeted therapy; Preclinical models; Clinical trials; Epidermal growth factor receptor5-FU, 5-fluorouracil; COX-2, cyclooxygenase-2; DNA-PKcs, DNA-dependent protein kinase, catalytic subunit;
Keywords: موتاسیون درمان هدفمند; KITENIN; Oral cancer; Neoplasm metastasis; Molecular targeted therapy;
Keywords: موتاسیون درمان هدفمند; Signaling pathway; Dose-response relationship; Neuronal plasticity; Molecular targeted therapy;
Keywords: موتاسیون درمان هدفمند; Aged; Colorectal neoplasms; Secondary; Molecular targeted therapy; Bevacizumab; Cohort studies
Keywords: موتاسیون درمان هدفمند; Optic; eye; ear; targeted therapy; molecular targeted therapy; ototoxicity
Surveillance de l'hypertension artérielle chez les patients traités par anti-angiogénique par voie orale en pratique quotidienne
Keywords: موتاسیون درمان هدفمند; Effets indésirables; Hypertension artérielle; Inhibiteurs de l'angiogenèse; Inhibiteur de la tyrosine kinase; Insuffisance rénale; Protéinurie; Thérapie moléculaire ciblée; Adverse effects; Angiogenesis inhibitors; Hypertension; Molecular target
Les cancers à petites cellules : que faire en cas de rechute ?
Keywords: موتاسیون درمان هدفمند; Cancer bronchique à petites cellules; Rechute; Chimiothérapie; Thérapie ciblée; Immunothérapie; Small cell lung carcinoma; Recurrence; Chemotherapy; Molecular targeted therapy; Immunotherapy;
Real world patterns of care in HER2-overexpressing breast cancer: Results of a survey of TEACH clinical trial investigators in 2011
Keywords: موتاسیون درمان هدفمند; Breast neoplasm; HER2; Health care disparities; Molecular targeted therapy;
Targeting MET in cancer therapy
Keywords: موتاسیون درمان هدفمند; Proto-oncogene protein c-MET; Antineoplastic agents; Protein kinase inhibitors; Molecular targeted therapy;
Immunohistochemical expression of epithelial cell adhesion molecule (EpCAM) in mucoepidermoid carcinoma compared to normal salivary gland tissues
Keywords: موتاسیون درمان هدفمند; EpCAM; Mucoepidermoid carcinoma; Salivary gland neoplasms; Head and neck neoplasms; Immunohistochemistry; Molecular targeted therapy;
Original ResearchPrognostic scores for sorafenib-treated hepatocellular carcinoma patients: A new application for the hepatoma arterial embolisation prognostic score
Keywords: موتاسیون درمان هدفمند; Molecular targeted therapy; Liver neoplasms; Prognosis; Sorafenib; Drug therapy;
Developing chemotherapy for diffuse pontine intrinsic gliomas (DIPG)
Keywords: موتاسیون درمان هدفمند; Biopsy; Brainstem glioma; Chemotherapy; Diffuse pontine intrinsic glioma; Molecular targeted therapy;
Original ResearchAdvanced chordoma treated by first-line molecular targeted therapies: Outcomes and prognostic factors. AÂ retrospective study of the French Sarcoma Group (GSF/GETO) and the Association des Neuro-Oncologues d'Expression Française (ANOCEF)
Keywords: موتاسیون درمان هدفمند; Chordoma; Molecular targeted therapy; Imatinib; Antiangiogenics; Anti-EGFR; Prognostic factors;
PET/Computed Tomography and Precision Medicine
Keywords: موتاسیون درمان هدفمند; Soft tissue sarcoma; Skeletal sarcoma; Molecular targeted therapy; PET; PET/CT;
Outcomes of Patients with Renal Cell Carcinoma and Sarcomatoid Dedifferentiation Treated with Nephrectomy and Systemic Therapies: Comparison between the Cytokine and Targeted Therapy Eras
Keywords: موتاسیون درمان هدفمند; kidney neoplasms; carcinoma; renal cell; neoplasm metastasis; molecular targeted therapy; cytokines; CCI; Charlson comorbidity index; IMDC; International Metastatic Renal Cell Carcinoma Database Consortium; MSKCC; Memorial Sloan Kettering Cancer Center; O
Role of Local Ablative Therapy in Patients with Oligometastatic and Oligoprogressive Non-Small Cell Lung Cancer
Keywords: موتاسیون درمان هدفمند; Local ablative therapy; NSCLC; Oligometastatic disease; Oligoprogressive disease; Molecular targeted therapy;
Increased life expectancy as a result of non-hormonal targeted therapies for HER2 or hormone receptor positive metastatic breast cancer: A systematic review and meta-analysis
Keywords: موتاسیون درمان هدفمند; Breast neoplasm; Molecular targeted therapy; Human epidermal growth factor receptor 2; Estrogen receptors; Progesterone receptors; Survival analysis;
Significance of survivin as a prognostic factor and a therapeutic target in endometrial cancer
Keywords: موتاسیون درمان هدفمند; Survivin; Prognosis; Apoptosis; Molecular targeted therapy; Endometrial cancer
Histomolecular profiling of pleomorphic, spindle cell, and giant cell carcinoma of the lung for targeted therapies
Keywords: موتاسیون درمان هدفمند; Sarcomatoid carcinoma; Lung neoplasms; Molecular targeted therapy; p40 protein; TTF1 protein
SCLC-State of the Art and What Does the Future Have in Store?
Keywords: موتاسیون درمان هدفمند; Chemotherapy; Genetics; Immune therapy; Molecular targeted therapy; Small-cell lung cancer;
Next-generation personalised medicine for high-risk paediatric cancer patients - The INFORM pilot study
Keywords: موتاسیون درمان هدفمند; Personalised medicine; Oncology; Paediatrics; Precision medicine; Molecular targeted therapy; Deep sequencing; Cancer; Sarcoma; Brain;
Progression-Free Survival, Response Rate, and Disease Control Rate as Predictors of Overall Survival in Phase IIIÂ Randomized Controlled Trials Evaluating the First-Line Chemotherapy for Advanced, Locally Advanced, and Recurrent Non-Small Cell Lung Carc
Keywords: موتاسیون درمان هدفمند; Postprogression survival; Surrogate marker; Cytotoxic agent; Molecular targeted therapy;
Actualités dans la prévention et la prise en charge du mélanome : implications et enjeux pour le pharmacien
Keywords: موتاسیون درمان هدفمند; Mélanome; Prévention; Thérapie ciblée; Immunothérapie; Pharmacien; Melanoma; Prevention and control; Immunotherapy; Molecular targeted therapy; Pharmacist;
Health-related quality of life impact in a randomised phase III study of the combination of dabrafenib and trametinib versus dabrafenib monotherapy in patients with BRAF V600 metastatic melanoma
Keywords: موتاسیون درمان هدفمند; Melanoma; Protein kinase inhibitors; Molecular targeted therapy; Proto-oncogene proteins B-raf; Dabrafenib; Trametinib;
Monotherapy Administration of Sorafenib in Patients With Non–Small Cell Lung Cancer (MISSION) Trial : A Phase III, Multicenter, Placebo-Controlled Trial of Sorafenib in Patients with Relapsed or Refractory Predominantly Nonsquamous Non–Small-Cell Lung Can
Keywords: موتاسیون درمان هدفمند; Non-small-cell lung cancer; Molecular targeted therapy; Sorafenib; KRAS mutation; EGFR mutation
CXCL14, CXCR7 expression and CXCR4 splice variant ratio associate with survival and metastases in Ewing sarcoma patients
Keywords: موتاسیون درمان هدفمند; Splice variant; Tumour microenvironment; Biomarker; Molecular targeted therapy;
Mechanisms of and therapeutic approaches for overcoming resistance to epidermal growth factor receptor (EGFR)-targeted therapy in squamous cell carcinoma of the head and neck (SCCHN)
Keywords: موتاسیون درمان هدفمند; Epidermal growth factor receptor; Molecular targeted therapy; Squamous cell carcinoma of the head and neck; Clinical trial; Drug resistance; HER2; HER3;
RAF signaling in neuroendocrine neoplasms: From bench to bedside
Keywords: موتاسیون درمان هدفمند; RAF; RAF-1; BRAF; MAPK; Neuroendocrine tumors; Neuroendocrine neoplasms; NET; Molecular targeted therapy; Cell signaling;
Early Pharmacodynamic Assessment Using 18F-Fluorodeoxyglucose Positron-Emission Tomography on Molecular Targeted Therapy and Cytotoxic Chemotherapy for Clinical Outcome Prediction
Keywords: موتاسیون درمان هدفمند; Cytotoxic chemotherapy; Epidermal growth factor receptor tyrosine kinase inhibitor; Gefitinib; Molecular targeted therapy; Non–small-cell lung cancer
RON (recepteur d'origine nantais) expression and its association with tumor progression in laryngeal squamous cell carcinoma
Keywords: موتاسیون درمان هدفمند; RON protein; Metastasis; Disease progression; Molecular targeted therapy; Laryngeal cancer;
Impact thérapeutique du diagnostic moléculaire des carcinomes bronchiques non à petites cellules métastatiques : les traitements ciblés en 2013
Keywords: موتاسیون درمان هدفمند; Cancer bronchique non à petites cellules métastatiques non résécable; Mutation; Fusion de gènes; Thérapies moléculaires ciblées; Résistance aux traitements; Unresectable metastatic non-small cell lung cancer; Mutation; Gene fusion; Molecular targ